U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789171) titled 'Synbiotic Supplementation as a Part of Dietary Modification in Multiple Sclerosis' on March 14.
Brief Summary: Multiple Sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system, influenced by genetic, epigenetic, and immunological factors, as well as environmental factors such as nutrition. Medical nutrition therapy (MNT) has the potential to improve the quality of life for individuals with MS and enhance the disease course, particularly by reducing inflammation, providing neural protection, and regulating metabolic factors such as body weight. Recently, probiotic/synbiotic-supported studies h...